SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.23 Cr | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-8.23 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹150 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.23 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹150 Cr | Positive | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹4,677.1 Cr | -8.9% | -13.2% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -8.9% |
-13.2% |
6.5% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses